Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
3.805
+0.385 (11.26%)
At close: Apr 28, 2026, 4:00 PM EDT
3.830
+0.025 (0.66%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Accendra Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Accendra Health stock have an average target of 3.38, with a low estimate of 2.75 and a high estimate of 4.00. The average target predicts a decrease of -11.17% from the current stock price of 3.81.
Analyst Consensus: Buy
* Price targets were last updated on Feb 20, 2026.
Analyst Ratings
The average analyst rating for Accendra Health stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Maintains $3 → $2.75 | Hold | Maintains | $3 → $2.75 | -27.73% | Feb 20, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $4 | Strong Buy | Maintains | $7 → $4 | +5.12% | Jan 9, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Aug 25, 2022 |
| Macquarie | Macquarie | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 3, 2020 |
Financial Forecast
Revenue This Year
2.62B
from 2.76B
Decreased by -5.29%
Revenue Next Year
2.73B
from 2.62B
Increased by 4.43%
EPS This Year
0.68
from -14.32
EPS Next Year
1.05
from 0.68
Increased by 55.57%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.7B | 3.0B | ||
| Avg | 2.6B | 2.7B | ||
| Low | 2.5B | 2.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.8% | 13.1% | ||
| Avg | -5.3% | 4.4% | ||
| Low | -9.5% | -2.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.80 | 1.33 | |||
| Avg | 0.68 | 1.05 | |||
| Low | 0.49 | 0.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 97.5% | |||
| Avg | - | 55.6% | |||
| Low | - | 17.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.